eternity report detail
eternity report detail
Bipolar Disorder Therapeutics Drugs Market

Bipolar Disorder Therapeutics Drugs Market Share, Size, Key Trends, Company Profiles, Regional Industry Analysis, Segmentation and Forecast To 2028

  • No of Pages: 129
  • Published On: Sep 2019
  • Format: PDF
  • Report ID : 13641

Report Summary

Eternity Insights has published a new study on Global Bipolar Disorder Therapeutics Drugs Market focusing on key segments as by Type (Olanzapine (Zyprexa),Quetiapine (Seroquel),Risperidone (Risperdal),Ariprazole (Abilify),Ziprasidone (Geodon),Clozapine (Clozaril)), by Application (lumateperone,Central Nervous System (CNS) Disorders, Other), and by region. This deep dive re-search report highlights the market and competitive intelligence across the key segments of the mar-ket. The report also considers the impact of COVID-19 on the global Bipolar Disorder Therapeutics Drugs Market.

The report considers 2018-2020 as historic period, 2021 as base year, and 2022-2028 as forecast period. The report includes quantitative analysis of the market supported by the market drivers, challenges, and trends to accurately map the market scenario and competition. Moreover, key insights related to market having direct impact on the market will also be covered.

Bipolar Disorder Therapeutics Drugs Market report is based on robust research methodology designed using blend of research ap-proaches developed using secondary/desk research and validated through the primary research and expert insights. Eternity Insights also uses paid data bases such as FACIVA, Hoovers, and other bench-marking and forecasting tools to provide accurate statistical analysis of supply and demand trends.

Global Bipolar Disorder Therapeutics Drugs Market Size, 2018-2028 (USD Million)

To learn more about this report

Global Bipolar Disorder Therapeutics Drugs Market Segmentation:

Bipolar Disorder Therapeutics Drugs Market, By Type

  • Olanzapine (Zyprexa)
  • Quetiapine (Seroquel)
  • Risperidone (Risperdal)
  • Ariprazole (Abilify)
  • Ziprasidone (Geodon)
  • Clozapine (Clozaril)

Bipolar Disorder Therapeutics Drugs Market, By Application

  • lumateperone
  • Central Nervous System (CNS) Disorders
  • Other

To learn more about this report

Geographically, the market is categorized in to five regions as North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. North America region dominates the global Bipolar Disorder Therapeutics Drugs market in terms of demand generation. The Bipolar Disorder Therapeutics Drugs market in Asia Pacific region is expected to grow at significantly high growth rate. The regional market is further sub-segmented and analyzed at granular level across key countries. The report will include market size and forecast for Bipolar Disorder Therapeutics Drugs market for below listed coun-tries across each region.

North America (U.S. and Canada), Europe (Germany, France, Italy, UK, Spain, and Rest of Europe), Asia Pacific (China, India, Japan, Australia, and Rest of Asia Pacific region); Latin America (Brazil, Mexico, and rest of the Latin America); Middle East and Africa (GCC, South Africa, and Rest of the Middle East and Africa).

Global Bipolar Disorder Therapeutics Drugs Market Taxonomy:

To learn more about this report

Global Bipolar Disorder Therapeutics Drugs Market Competitive Landscape

The global Bipolar Disorder Therapeutics Drugs market analysis report covers detailed analysis of competitive scenario across globe. The report includes profiles of leading players covering below details

  • Company Overview
  • Financial Analysis
  • Product Portfolio Analysis
  • Strategic Overview
  • SWOT Analysis

List of Companies Profiled in the report:

  • AstraZeneca
  • Allergan
  • Bristol-Myers Squibb
  • GSK
  • Janssen
  • AbbVie
  • Youdim
  • Delpor
  • Lundbeck
  • Intra-Cellular Therapies
  • Novartis Pharmaceuticals Corporation
  • Noven Pharmaceuticals
  • Otsuka
  • Pfizer
  • Reviva Pharmaceuticals
  • Other Players of Specific Interest can be added based on requirement

Market Segmentation

Report Attributes Details
The market size value in 2021 USD XX.XX Million
CAGR (2021 - 2028) XX.XX %
The Revenue forecast in 2028 USD XX.XX Million
Base year for estimation 2021
Historical data 2018-2019
Forecast period 2022-2028
Quantitative units
  • Revenue in USD Million
  • CAGR from 2021 to 2028
Report coverage Revenue forecast, company ranking, competitive landscape, growth factors, and trends
Segments covered By Type Outlook, Application Outlook, Regional Outlook
By Type Outlook Olanzapine (Zyprexa),Quetiapine (Seroquel),Risperidone (Risperdal),Ariprazole (Abilify),Ziprasidone (Geodon),Clozapine (Clozaril)
By Application Outlook lumateperone,Central Nervous System (CNS) Disorders, Other
Regional scope North America, Europe, Asia Pacific, Latin America, Middle East & Africa
Country scope U.S., Canada, U.K., Germany, France, BENELUX, China, India, Japan, South Korea, Brazil, Saudi Arabia, UAE, Turkey
Key companies profiled AstraZeneca,Allergan,Bristol-Myers Squibb,GSK,Janssen,AbbVie,Youdim,Delpor,Lundbeck,Intra-Cellular Therapies,Novartis Pharmaceuticals Corporation,Noven Pharmaceuticals,Otsuka,Pfizer,Reviva Pharmaceuticals
Customization Available Yes, the report can be tailored to meet your specific requirements.

Key Benefits to the stake holders

  • Qualitative and quantitative analysis of the market based on segmentation involving both economic as well as non-economic factors
  • Provision of market value (USD Billion) and volume (Tons) data for each segment and sub-segment
  • Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
  • Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
  • Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions and acquisitions in the past five years of companies profiled
  • Extensive company profiles comprising of company overview, company insights, product benchmarking and SWOT analysis for the major market players
  • The current as well as the future market outlook of the industry with respect to recent developments (which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
  • Includes an in-depth analysis of the market of various perspectives through Porter’s five forces analysis
  • Provides insight into the market through Value Chain
  • Market dynamics scenario, along with growth opportunities of the market in the years to come

Table Of Contents

Table of Contents

1 Study Coverage
1.1 Bipolar Disorder Therapeutics Drugs Product Introduction
1.2 Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Bipolar Disorder Therapeutics Drugs Market Size Growth Rate by Type
1.4.2 Olanzapine (Zyprexa)
1.4.3 Quetiapine (Seroquel)
1.4.4 Risperidone (Risperdal)
1.4.5 Ariprazole (Abilify)
1.4.6 Ziprasidone (Geodon)
1.4.7 Clozapine (Clozaril)
1.5 Market by Application
1.5.1 Global Bipolar Disorder Therapeutics Drugs Market Size Growth Rate by Application
1.5.2 lumateperone
1.5.3 Central Nervous System (CNS) Disorders
1.6 Study Objectives
1.7 Years Considered

2 Executive Summary
2.1 Global Bipolar Disorder Therapeutics Drugs Market Size
2.1.1 Global Bipolar Disorder Therapeutics Drugs Revenue 2014-2025
2.1.2 Global Bipolar Disorder Therapeutics Drugs Sales 2014-2025
2.2 Bipolar Disorder Therapeutics Drugs Growth Rate by Regions
2.2.1 Global Bipolar Disorder Therapeutics Drugs Sales by Regions
2.2.2 Global Bipolar Disorder Therapeutics Drugs Revenue by Regions

3 Breakdown Data by Manufacturers
3.1 Bipolar Disorder Therapeutics Drugs Sales by Manufacturers
3.1.1 Bipolar Disorder Therapeutics Drugs Sales by Manufacturers
3.1.2 Bipolar Disorder Therapeutics Drugs Sales Market Share by Manufacturers
3.2 Bipolar Disorder Therapeutics Drugs Revenue by Manufacturers
3.2.1 Bipolar Disorder Therapeutics Drugs Revenue by Manufacturers (2014-2019)
3.2.2 Bipolar Disorder Therapeutics Drugs Revenue Share by Manufacturers (2014-2019)
3.3 Bipolar Disorder Therapeutics Drugs Price by Manufacturers
3.4 Bipolar Disorder Therapeutics Drugs Manufacturing Base Distribution, Product Types
3.4.1 Bipolar Disorder Therapeutics Drugs Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Bipolar Disorder Therapeutics Drugs Product Type
3.4.3 Date of International Manufacturers Enter into Bipolar Disorder Therapeutics Drugs Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type
4.1 Global Bipolar Disorder Therapeutics Drugs Sales by Type
4.2 Global Bipolar Disorder Therapeutics Drugs Revenue by Type
4.3 Bipolar Disorder Therapeutics Drugs Price by Type

5 Breakdown Data by Application
5.1 Overview
5.2 Global Bipolar Disorder Therapeutics Drugs Breakdown Data by Application

6 North America
6.1 North America Bipolar Disorder Therapeutics Drugs by Country
6.1.1 North America Bipolar Disorder Therapeutics Drugs Sales by Country
6.1.2 North America Bipolar Disorder Therapeutics Drugs Revenue by Country
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America Bipolar Disorder Therapeutics Drugs by Type
6.3 North America Bipolar Disorder Therapeutics Drugs by Application

7 Europe
7.1 Europe Bipolar Disorder Therapeutics Drugs by Country
7.1.1 Europe Bipolar Disorder Therapeutics Drugs Sales by Country
7.1.2 Europe Bipolar Disorder Therapeutics Drugs Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe Bipolar Disorder Therapeutics Drugs by Type
7.3 Europe Bipolar Disorder Therapeutics Drugs by Application

8 Asia Pacific
8.1 Asia Pacific Bipolar Disorder Therapeutics Drugs by Region
8.1.1 Asia Pacific Bipolar Disorder Therapeutics Drugs Sales by Region
8.1.2 Asia Pacific Bipolar Disorder Therapeutics Drugs Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Thailand
8.1.10 Malaysia
8.1.11 Philippines
8.1.12 Vietnam
8.2 Asia Pacific Bipolar Disorder Therapeutics Drugs by Type
8.3 Asia Pacific Bipolar Disorder Therapeutics Drugs by Application

9 Central & South America
9.1 Central & South America Bipolar Disorder Therapeutics Drugs by Country
9.1.1 Central & South America Bipolar Disorder Therapeutics Drugs Sales by Country
9.1.2 Central & South America Bipolar Disorder Therapeutics Drugs Revenue by Country
9.1.3 Brazil
9.2 Central & South America Bipolar Disorder Therapeutics Drugs by Type
9.3 Central & South America Bipolar Disorder Therapeutics Drugs by Application

10 Middle East and Africa
10.1 Middle East and Africa Bipolar Disorder Therapeutics Drugs by Country
10.1.1 Middle East and Africa Bipolar Disorder Therapeutics Drugs Sales by Country
10.1.2 Middle East and Africa Bipolar Disorder Therapeutics Drugs Revenue by Country
10.1.3 Turkey
10.1.4 GCC Countries
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa Bipolar Disorder Therapeutics Drugs by Type
10.3 Middle East and Africa Bipolar Disorder Therapeutics Drugs by Application

11 Company Profiles
11.1 AstraZeneca
11.1.1 AstraZeneca Company Details
11.1.2 Company Business Overview
11.1.3 AstraZeneca Bipolar Disorder Therapeutics Drugs Sales, Revenue and Gross Margin (2014-2019)
11.1.4 AstraZeneca Bipolar Disorder Therapeutics Drugs Products Offered
11.1.5 AstraZeneca Recent Development
11.2 Allergan
11.2.1 Allergan Company Details
11.2.2 Company Business Overview
11.2.3 Allergan Bipolar Disorder Therapeutics Drugs Sales, Revenue and Gross Margin (2014-2019)
11.2.4 Allergan Bipolar Disorder Therapeutics Drugs Products Offered
11.2.5 Allergan Recent Development
11.3 Bristol-Myers Squibb
11.3.1 Bristol-Myers Squibb Company Details
11.3.2 Company Business Overview
11.3.3 Bristol-Myers Squibb Bipolar Disorder Therapeutics Drugs Sales, Revenue and Gross Margin (2014-2019)
11.3.4 Bristol-Myers Squibb Bipolar Disorder Therapeutics Drugs Products Offered
11.3.5 Bristol-Myers Squibb Recent Development
11.4 GSK
11.4.1 GSK Company Details
11.4.2 Company Business Overview
11.4.3 GSK Bipolar Disorder Therapeutics Drugs Sales, Revenue and Gross Margin (2014-2019)
11.4.4 GSK Bipolar Disorder Therapeutics Drugs Products Offered
11.4.5 GSK Recent Development
11.5 Janssen
11.5.1 Janssen Company Details
11.5.2 Company Business Overview
11.5.3 Janssen Bipolar Disorder Therapeutics Drugs Sales, Revenue and Gross Margin (2014-2019)
11.5.4 Janssen Bipolar Disorder Therapeutics Drugs Products Offered
11.5.5 Janssen Recent Development
11.6 AbbVie
11.6.1 AbbVie Company Details
11.6.2 Company Business Overview
11.6.3 AbbVie Bipolar Disorder Therapeutics Drugs Sales, Revenue and Gross Margin (2014-2019)
11.6.4 AbbVie Bipolar Disorder Therapeutics Drugs Products Offered
11.6.5 AbbVie Recent Development
11.7 Youdim
11.7.1 Youdim Company Details
11.7.2 Company Business Overview
11.7.3 Youdim Bipolar Disorder Therapeutics Drugs Sales, Revenue and Gross Margin (2014-2019)
11.7.4 Youdim Bipolar Disorder Therapeutics Drugs Products Offered
11.7.5 Youdim Recent Development
11.8 Delpor
11.8.1 Delpor Company Details
11.8.2 Company Business Overview
11.8.3 Delpor Bipolar Disorder Therapeutics Drugs Sales, Revenue and Gross Margin (2014-2019)
11.8.4 Delpor Bipolar Disorder Therapeutics Drugs Products Offered
11.8.5 Delpor Recent Development
11.9 Lundbeck
11.9.1 Lundbeck Company Details
11.9.2 Company Business Overview
11.9.3 Lundbeck Bipolar Disorder Therapeutics Drugs Sales, Revenue and Gross Margin (2014-2019)
11.9.4 Lundbeck Bipolar Disorder Therapeutics Drugs Products Offered
11.9.5 Lundbeck Recent Development
11.10 Intra-Cellular Therapies
11.10.1 Intra-Cellular Therapies Company Details
11.10.2 Company Business Overview
11.10.3 Intra-Cellular Therapies Bipolar Disorder Therapeutics Drugs Sales, Revenue and Gross Margin (2014-2019)
11.10.4 Intra-Cellular Therapies Bipolar Disorder Therapeutics Drugs Products Offered
11.10.5 Intra-Cellular Therapies Recent Development
11.11 Novartis Pharmaceuticals Corporation
11.12 Noven Pharmaceuticals
11.13 Otsuka
11.14 Pfizer
11.15 Reviva Pharmaceuticals

12 Future Forecast
12.1 Bipolar Disorder Therapeutics Drugs Market Forecast by Regions
12.1.1 Global Bipolar Disorder Therapeutics Drugs Sales Forecast by Regions 2019-2025
12.1.2 Global Bipolar Disorder Therapeutics Drugs Revenue Forecast by Regions 2019-2025
12.2 Bipolar Disorder Therapeutics Drugs Market Forecast by Type
12.2.1 Global Bipolar Disorder Therapeutics Drugs Sales Forecast by Type 2019-2025
12.2.2 Global Bipolar Disorder Therapeutics Drugs Revenue Forecast by Type 2019-2025
12.3 Bipolar Disorder Therapeutics Drugs Market Forecast by Application
12.4 North America Bipolar Disorder Therapeutics Drugs Forecast
12.5 Europe Bipolar Disorder Therapeutics Drugs Forecast
12.6 Asia Pacific Bipolar Disorder Therapeutics Drugs Forecast
12.7 Central & South America Bipolar Disorder Therapeutics Drugs Forecast
12.8 Middle East and Africa Bipolar Disorder Therapeutics Drugs Forecast

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Macroscopic Indicators

14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Bipolar Disorder Therapeutics Drugs Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer

Choose License Type

Request Sample Ask For Customization Inquire Before Buying Ask for Discount

Need Assistance?

We will be happy to help you find what you need. Please call us or write to us:
+91-930-705-6852 sales@eternityinsights.com

Why Eternity Insights?

INFLALLIBLE METHODOLOGY

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

ANALYST SUPPORT

For complete satisfaction

CUSTOMIZATION

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers

AGILE APPROACH

A faster and efficient way to cater to the needs with continuous iteration

Frequently Asked Questions on this Report

The Bipolar Disorder Therapeutics Drugs Market is segmented based on Type, Application, and by region.

AstraZeneca,Allergan,Bristol-Myers Squibb,GSK,Janssen,AbbVie,Youdim,Delpor,Lundbeck,Intra-Cellular Therapies,Novartis Pharmaceuticals Corporation,Noven Pharmaceuticals,Otsuka,Pfizer andReviva Pharmaceuticals are the leading players of global Bipolar Disorder Therapeutics Drugs market.

The forecast period would be from 2022 to 2030 in the market report with year 2021 as a base year.

Factors such as competitive strength and market positioning are key areas considered while selecting top companies to be profiled.
eternity report detail

To learn more about this report

Similar Reports
What Sets Us Apart?
eternity-quality-assurance
Quality Assurance

Focus on Data Accuracy & Reliability

eternity-trust
Trusted by the Best

75+ Clients in Fortune 500

eternity-privacy-security
Privacy and Security

All your transactions are secured end-to-end, ensuring a satisfactory purchase

eternity-value-for-money
Value for Money

Ensure the best and affordable pricing

Our Happy Customers
Some of our customer review
Our Clients
Our capabilities includes
...
Market intelligence
  • Market Sizing And Forecasting
  • Growth Drivers And Challenges
  • Key Industry Trends Analysis
  • Porters Five Forces Analysis
  • Demand Gap Analysis
...
Consumer Behavior Mapping
  • Consumer Purchase Behaviour Analysis
  • Customer Satisfaction & Loyalty Analysis
  • Concept/Product Testing
  • Campaign Effectiveness And Ad Testing Research
...
Market Entry and Expansion Strategy
  • Market Opportunity Assessment
  • Merger & Acquisition Analysis
  • Go-to-market Strategy
  • Blue Ocean Strategy
  • Investment Due Diligence
  • Value Chain Analysis Consulting Solutions
  • Business Model Research
  • Innovation Analysis
  • Technology Portfolio Assessment
  • Influencer Mapping
  • Social Media Research
  • Supplier, Distributor And Partner Identification
...
Competitive Intelligence
  • Company Profiles with detailed Financial Analysis
  • Product Portfolio Analysis
  • Market Share Analysis
  • Product Pricing Analysis
  • Winning Imperatives of Leading Players
  • Marketing and Market Penetration Strategies
  • Product Pipeline Analysis
  • Conference Coverage
  • SWOT Analysis